Evans John M. — SEC insider filings

SEC reporting owner CIK 1786304. 33 insider filings on record with FilingPulse; latest filed 2026-10-16.

Transaction summary — filings shown

Covers all 33 filings on record, filed 2020-08-17 to 2026-10-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Beam Therapeutics Inc. (BEAM)CEO, Director32—105 legs · 956,758 sh · $39,818,34668
Verve Therapeutics, Inc. (VERV)Director1——1

Insider filings — Evans John M.

FiledFormIssuerReported transactionsSource
2026-10-164Beam Therapeutics Inc. (BEAM)Option exercise (M): 25,000 @ $1.03 · Sale (S): 25,000 @ $23.57 · Option exercise (M): 25,000 @ $1.03 · Sale (S): 25,000 @ $23.98 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2026-07-014Beam Therapeutics Inc. (BEAM)Option exercise (M): 18,663 @ $0.67 · Option exercise (M): 6,337 @ $1.03 · Sale (S): 13,421 @ $35.13 · Sale (S): 11,579 @ $35.91 · Option exercise (M): 25,000 @ $1.03 · Sale (S): 23,100 @ $34.26 · +4 moreEDGAR
2026-04-064Beam Therapeutics Inc. (BEAM)Sale (S): 30,078 @ $24.58EDGAR
2026-04-014Beam Therapeutics Inc. (BEAM)Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $22.37 · Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $22.76 · Grant/award (A): 90,000 @ $0 · Option exercise (M): 25,000 (derivative) @ $0 · +1 moreEDGAR
2026-02-024Beam Therapeutics Inc. (BEAM)Option exercise (M): 19,336 @ $0.67 · Option exercise (M): 5,664 @ $0.67 · Sale (S): 16,333 @ $29.19 · Sale (S): 8,667 @ $29.74 · Option exercise (M): 25,000 @ $0.67 · Sale (S): 22,094 @ $28.27 · +5 moreEDGAR
2025-10-034Beam Therapeutics Inc. (BEAM)Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $24.51 · Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $24.63 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2025-04-034Beam Therapeutics Inc. (BEAM)Sale (S): 30,663 @ $18.35EDGAR
2025-04-024/ABeam Therapeutics Inc. (BEAM)Option exercise (M): 30,000 @ $0.67 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2025-04-024Beam Therapeutics Inc. (BEAM)Grant/award (A): 77,500 @ $0EDGAR
2025-02-034Beam Therapeutics Inc. (BEAM)Sale (S): 29,800 @ $26.75 · Sale (S): 200 @ $27.28 · Grant/award (A): 155,000 (derivative) @ $0EDGAR
2024-10-024Beam Therapeutics Inc. (BEAM)Sale (S): 60,000 @ $24.60EDGAR
2024-06-284Beam Therapeutics Inc. (BEAM)Sale (S): 60,000 @ $24.50EDGAR
2024-04-034Beam Therapeutics Inc. (BEAM)Sale (S): 18,102 @ $32.13 · Grant/award (A): 99,336 (derivative) @ $0 · Grant/award (A): 53,965 (derivative) @ $0EDGAR
2024-04-014Beam Therapeutics Inc. (BEAM)Sale (S): 60,000 @ $33.86 · Grant/award (A): 77,500 @ $0EDGAR
2024-02-024Beam Therapeutics Inc. (BEAM)Sale (S): 60,000 @ $25.33 · Grant/award (A): 155,000 (derivative) @ $24.40EDGAR
2023-04-054Beam Therapeutics Inc. (BEAM)Sale (S): 5,161 @ $30.31 · Sale (S): 6,493 @ $29.09EDGAR
2023-03-314Beam Therapeutics Inc. (BEAM)Code (L): 225 @ $0 · Grant/award (A): 56,250 @ $0 · Option exercise (M): 13,850 @ $7.22 · Grant/award (A): 112,500 (derivative) @ $0 · Option exercise (M): 13,850 (derivative) @ $0EDGAR
2022-11-024Beam Therapeutics Inc. (BEAM)Sale (S): 7,567 @ $44.92 · Sale (S): 7,768 @ $46.19 · Sale (S): 11,756 @ $46.88 · Sale (S): 2,909 @ $47.89 · Sale (S): 5,008 @ $44.93 · Sale (S): 4,569 @ $46.19 · +2 moreEDGAR
2022-07-294Beam Therapeutics Inc. (BEAM)Sale (S): 10,181 @ $64.87 · Sale (S): 15,236 @ $65.82 · Sale (S): 1,562 @ $66.74 · Sale (S): 2,848 @ $67.80 · Sale (S): 173 @ $68.49 · Sale (S): 6,953 @ $64.88 · +3 moreEDGAR
2022-06-134Verve Therapeutics, Inc. (VERV)Grant/award (A): 15,500 (derivative) @ $0EDGAR
2022-05-024Beam Therapeutics Inc. (BEAM)Option exercise (M): 12,246 @ $7.22 · Option exercise (M): 47,204 @ $1.03 · Sale (S): 3,900 @ $36.59 · Sale (S): 13,655 @ $37.48 · Sale (S): 6,842 @ $38.32 · Sale (S): 4,503 @ $39.49 · +8 moreEDGAR
2022-04-044Beam Therapeutics Inc. (BEAM)Grant/award (A): 56,250 @ $0 · Sale (S): 6,261 @ $59.11EDGAR
2022-02-024/ABeam Therapeutics Inc. (BEAM)Gift (G): 12,000 @ $0 · Sale (S): 801 @ $63.79 · Sale (S): 2,172 @ $64.47 · Sale (S): 3,177 @ $65.49 · Sale (S): 6,337 @ $66.55 · Sale (S): 13,535 @ $67.44 · +10 moreEDGAR
2021-10-084Beam Therapeutics Inc. (BEAM)Option exercise (M): 27,700 @ $1.03 · Sale (S): 3,149 @ $82.72 · Sale (S): 13,406 @ $83.47 · Sale (S): 10,444 @ $84.45 · Sale (S): 701 @ $85.19 · Sale (S): 2,171 @ $82.71 · +4 moreEDGAR
2021-09-214/ABeam Therapeutics Inc. (BEAM)Grant/award (A): 99,336 (derivative) @ $0 · Grant/award (A): 53,964 (derivative) @ $0EDGAR
2021-08-204Beam Therapeutics Inc. (BEAM)Sale (S): 400 @ $96.38 · Sale (S): 1,000 @ $97.50 · Sale (S): 3,140 @ $98.74 · Sale (S): 9,704 @ $99.53 · Sale (S): 5,456 @ $100.35 · Sale (S): 300 @ $101 · +2 moreEDGAR
2021-07-084Beam Therapeutics Inc. (BEAM)Option exercise (M): 25,000 @ $1.03 · Sale (S): 645 @ $100.69 · Sale (S): 2,300 @ $101.27 · Sale (S): 100 @ $102 · Sale (S): 2,864 @ $103.52 · Sale (S): 1,336 @ $104.40 · +9 moreEDGAR
2021-06-304Beam Therapeutics Inc. (BEAM)Code (L): 32 @ $0 · Code (L): 32 @ $0 · Other (J): 32 @ $0EDGAR
2021-04-234Beam Therapeutics Inc. (BEAM)Sale (S): 1,463 @ $67.90 · Sale (S): 5,079 @ $69.02 · Sale (S): 5,595 @ $70.23 · Sale (S): 9,869 @ $71.38 · Sale (S): 2,994 @ $71.79 · Option exercise (M): 6,000 @ $1.03 · +1 moreEDGAR
2021-04-124Beam Therapeutics Inc. (BEAM)Code (L): 33 @ $0 · Code (L): 32 @ $0 · Code (L): 32 @ $0EDGAR
2021-04-024Beam Therapeutics Inc. (BEAM)Grant/award (A): 69,375 @ $0 · Grant/award (A): 138,750 (derivative) @ $0EDGAR
2021-01-044Beam Therapeutics Inc. (BEAM)Sale (S): 1,366 @ $81.14 · Sale (S): 4,100 @ $82.33 · Sale (S): 4,925 @ $83.76 · Sale (S): 1,422 @ $85.35 · Sale (S): 7,196 @ $86.21 · Sale (S): 504 @ $86.79 · +2 moreEDGAR
2020-08-174Beam Therapeutics Inc. (BEAM)Option exercise (M): 115,000 @ $1.03 · Option exercise (M): 115,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1786304 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs